Eiger Mountains
Webcast ImageWebcast
Eiger BioPharmaceuticals at the Wedbush PacGrow Healthcare Conference  (Replay)
08/16/17 at 12:45 p.m. ET
Eiger BioPharmaceuticals at the Wedbush PacGrow Healthcare Conference
Wednesday, August 16, 2017 12:45 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Corporate Profile
Eiger is a clinical-stage biopharmaceutical company committed to developing and commercializing novel products for the treatment of Orphan diseases. Eiger has built a diverse, late-stage portfolio of well-characterized product candidates with the potential to address diseases for which the unmet medical need is high, a novel biology for treatment has been identified, and for which an effective therapy is urgently needed. The Eiger management team has extensive experience in the clinical development... More >>
Stock Quote
EIGR (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$8.00
Change (%)0.00 (0.00%)
Volume0
Data as of 08/16/17 4:00 p.m. ET
Refresh quote
Recent NewsMore >>
DateTitle
08/14/17Eiger BioPharmaceuticals Reports Second Quarter 2017 Financial Results
08/08/17Eiger BioPharmaceuticals to Present at 2017 Wedbush PacGrow Healthcare Conference on August 16th
07/27/17Eiger Announces FDA Fast Track Designation Granted for Pegylated Interferon Lambda in Hepatitis Delta Virus Infection
07/24/17Eiger Completes Enrollment in Phase 2 LIMT HDV Study of Pegylated Interferon Lambda in Hepatitis Delta Virus Infection
Upcoming EventsMore >>
DateTitle
09/08/17
Eiger BioPharmaceuticals at the Biocentury Newsmakers in The Biotech Industry
LocationMillenium Broadway Hotel and Conference Center
New York, NY
09/10/17
through
09/12/17
Eiger BioPharmaceuticals at the Rodman & Renshaw 19th Annual Global Investment Conference
11/15/17
through
11/16/17
Eiger BioPharmaceuticals at the Jeffries London Healthcare Conference
LocationWaldorf Hilton, London
What's New
There are currently no items available.
Receive E-mail Alerts
Sign up to receive e-mail alerts whenever Eiger BioPharmaceuticals posts new information to the site. Just enter your e-mail address and click Submit.
 
Data provided by Nasdaq. Minimum 15 minutes delayed.